(Q56671815)

https://api.crossref.org/works/10.1007%2FS00347-012-2638-4

The dilution of benzalkonium chloride (BAK) in the tear film.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2638-4

Travoprost 0.004% with and without benzalkonium chloride: a comparison of safety and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2638-4

Corneal penetration into rabbit aqueous humor is comparable between preserved and preservative-free tafluprost

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2638-4

A rabbit dry eye model induced by topical medication of a preservative benzalkonium chloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2638-4

Effect of timolol with and without preservative on the basal tear turnover in glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2638-4

How the most common preservative affects the Meibomian lipid layer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2638-4

An in vivo confocal microscopy analysis of effects of topical antiglaucoma therapy with preservative on corneal innervation and morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2638-4

Associations between elevated intraocular pressure and glaucoma, use of glaucoma medications, and 5-year incident cataract: the Blue Mountains Eye Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2638-4

Topical ocular hypotensive medication and lens opacification: evidence from the ocular hypertension treatment study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2638-4

Human lens epithelial cell damage and stimulation of their secretion of chemical mediators by benzalkonium chloride rather than latanoprost and timolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2638-4

ESCRS Binkhorst Lecture 2002: Pseudophakic preservative maculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2638-4

Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2638-4

Allergic contact dermatitis from timolol and dorzolamide eye drops

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2638-4

Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2638-4

Evaluation of practice patterns for the care of open-angle glaucoma compared with claims data: the Glaucoma Adherence and Persistency Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2638-4

Adherence and persistence with glaucoma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2638-4

Patient persistency with topical ocular hypotensive therapy in a managed care population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2638-4

Persistency with latanoprost or timolol in primary open-angle glaucoma suspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2638-4

Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2638-4

Compliance Barriers in Glaucoma: A Systematic Classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2638-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2638-4

Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2638-4

Corneal and conjunctival changes caused by commonly used glaucoma medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2638-4

Conventional patch tests are poor detectors of contact allergy from ophthalmic products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-012-2638-4

[Preservative-free timolol eye drops--surface-anesthetic effect and local compatibility]

21 January 2018

1 reference

12 December 2020

Microbial contamination of eye drops

1 reference

12 December 2020

Ocular symptoms and signs with preserved and preservative-free glaucoma medications

1 reference

12 December 2020

Topical timolol with and without benzalkonium chloride: epithelial permeability and autofluorescence of the cornea in glaucoma

1 reference

12 December 2020

Are multidose over-the-counter artificial tears adequately preserved?

1 reference

12 December 2020

Microbial contamination of multiply used preservative-free artificial tears packed in reclosable containers

1 reference

12 December 2020

[Pros and cons of preservatives in eyedrops. Questionnaire for practitioners and experimental studies with reference to the requirements of the German Pharmacopoeia of August 1978]

1 reference

12 December 2020

Rates of discontinuation and change of glaucoma therapy in a managed care setting.

1 reference

12 December 2020